Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 1010-1017
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1010
Table 1 Reverse transcription polymerase chain reaction primers
Gene namePrimer sequenceProduct length, bp
Fasforward: 5′-GAATGCAAGGGACTGATAGC-3′414
Reverse: 5′-TGGTTCGTGTGCAAGGCTC-3′
FasLforward: 5′-GGAATGGGAAGACACATATGGAACTGC-3′239
Reverse: 5′-CATATCTGGCCAGTAGTGCAGTAATT-3′
Caspase-3forward: 5′-GCTATTGTGAGGCGGTTGT-3′270
Reverse: 5′-CGTTTGGAGTCCCTTTGT-3′
Caspase-8forward: 5′-TCTGGAGCATCTGCTGTCTG-3′427
Reverse: 5′-TTGACGTCTGTGGTCCGTCC-3′
p53forward: 5′-CTTTCAACTCTGTCTCCTTC-3′180
Reverse: 5′-TGGGCAACCAGCCCTGTCGT-3′
Bcl-2forward: 5′-CAGCTGCACCTGACGCCCTT-3′231
Reverse: 5′-GCCTCCGTTATCCTGGATCC-3′
β-actinforward: 5′-ACACTGTGCCCATCTACGAGG-3′621
Reverse: 5′-AGGGGCCGGACTCGTCATACT-3′
Table 2 Comparison of the inhibition rates of proliferation of hepatocellular carcinoma SMMC-7721 cells in the groups with different Solanum lyratum Thumb concentrations, -x ± s
GroupConcentration, mg/LnOD valueInhibition rate, %
Three ST groups with different concentrations2.5121.516 ± 0.20518.22 ± 2.32
5121.242 ± 0.23636.56 ± 2.51
10120.815 ± 0.27655.98 ± 3.12
Negative control group0121.842 ± 0.183-
Positive control group2.5121.135 ± 0.17238.60 ± 1.78
Table 3 Comparison of apoptosis rates of hepatocellular carcinoma SMMC-7721 cells in different groups, -x ± s
GroupConcentration, C/mg•L-1Apoptosis rate of SMMC-7721 cells, %
Three ST groups with different concentrations2.510.75 ± 2.51
517.31 ± 2.33
1030.21 ± 3.62
Negative control group03.75 ± 1.23
Positive control group2.517.36 ± 1.62
Table 4 mRNA expressions of genes relating to hepatocellular carcinoma SMMC-7721 cells in each group
GroupConcentration, C/mg•L-1mRNA expression of genes
FasFasLCaspase-8Caspase-3p53Bcl-2β-actin
Three ST groups with different concentrations2.552.47 ± 0.1058.25 ± 0.5130.57 ± 0.1022.15 ± 0.0234.17 ± 0.0136.28 ± 0.1417.53 ± 0.14
552.74 ± 0.0856.81 ± 0.3030.76 ± 0.0322.33 ± 0.0934.45 ± 0.2035.40 ± 0.5118.15 ± 0.41
1053.41 ± 0.6455.94 ± 0.8031.30 ± 0.2423.01 ± 0.4735.11 ± 0.6933.54 ± 0.5119.10 ± 0.91
Negative control group052.32 ± 0.0459.13 ± 0.0730.44 ± 0.0622.05 ± 0.0334.11 ± 0.0237.59 ± 0.3317.30 ± 0.17
Positive control group2.552.79 ± 0.1156.69 ± 0.3430.77 ± 0.0322.35 ± 0.1234.43 ± 0.2035.53 ± 0.3518.18 ± 0.41
Table 5 Differences in mRNA expressions of genes relating to hepatocellular carcinoma SMMC-7721 cells in each group
GroupConcentration, C/mg•L-12-ΔΔCT
FasFasLCaspase-8Caspase-3p53Bcl-2
Negative control group0111111
Three ST groups with different concentrations2.51.06 ± 0.062.30 ± 0.93a1.08 ± 0.041.10 ± 0.121.13 ± 0.113.09 ± 0.59a
51.34 ± 0.25a9.02 ± 0.32b1.47 ± 0.31a1.50 ± 0.27a1.43 ± 0.16a9.46 ± 0.58b
101.63 ± 0.14a31.34 ± 0.13b2.02 ± 0.71a1.82 ± 0.40a1.75 ± 0.25a47.29 ± 0.68b
Positive control group51.33 ± 0.17a10.02 ± 0.57b1.49 ± 0.30a1.50 ± 0.19a1.47 ± 0.11a8.92 ± 0.09b